Bristol Myers Liver Cancer Treatment Meets Main Goal Of Late-stage Study Bristol Myers Liver Cancer Treatment Meets Main Goal Of Late-stage Study
Bristol Myers Squibb said on Wednesday a combination of its drugs, Opdivo and Yervoy, met the main goal of a late-stage study evaluating it as an initial treatment for a...Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 20, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
Bristol Myers' Opdivo-Yervoy Combo Meets Main Goal in Liver Cancer Trial Bristol Myers' Opdivo-Yervoy Combo Meets Main Goal in Liver Cancer Trial
Bristol Myers Squibb said on Wednesday a combination of Opdivo and Yervoy met the main goal of a late-stage study evaluating it as an initial treatment for a type of liver...Reuters Health Information (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 20, 2024 Category: Internal Medicine Tags: Hematology-Oncology Source Type: news
Ultrasound model predicts liver disease progress
A predictive model combining multiple ultrasonic parameters could discriminate between different liver diseases in a study published March 19 in Radiology.
A team of researchers led by Fangyi Liu, MD, from the Chinese PLA General Hospital in Beijing, found that their multiparametric ultrasound model can predict metabolic dysfunction-associated steatohepatitis (MASH) in patients with metabolic dysfunction-associated fatty liver disease (MAFLD), regardless of hepatitis B virus infection status.
“These findings are important for noninvasive assessment of the MAFLD disease process,” the Liu team wrote.
Previous studies ...
Source: AuntMinnie.com Headlines - March 20, 2024 Category: Radiology Authors: Amerigo Allegretto Tags: Clinical News Ultrasound Genitourinary Radiology Source Type: news
Teamwork Enables Transplant for Those With Obesity, ESRD Teamwork Enables Transplant for Those With Obesity, ESRD
A collaborative program between bariatric and transplant teams enabled patients with morbid obesity and end-stage renal disease to become eligible for a kidney transplant.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - March 19, 2024 Category: Transplant Surgery Tags: Nephrology Source Type: news
What Do Sex Therapists Do? (Hint: It's Not What You Think) What Do Sex Therapists Do? (Hint: It's Not What You Think)
When it comes to sexual health, if you don ' t ask, patients won ' t tell. Plus: how to find a sex therapist.Medscape Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 19, 2024 Category: Consumer Health News Tags: Family Medicine/Primary Care Commentary Source Type: news
XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial
CALGARY, Alberta, March 19, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the "Company") XRTXXRTXANUA)), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to provide a summary of Company's…#calgary #alberta #xortxtherapeuticsinc #xortx #allendavidoff #autosomaldominant #fda #usfda #xorlo #boardofdirectors (Source: Reuters: Health)
Source: Reuters: Health - March 19, 2024 Category: Consumer Health News Source Type: news
The PACSman Pontificates: Dog tired after HIMSS 2024
Michael J. Cannavo.Lying in bed the night after my visit to the Healthcare Information and Management Systems Society (HIMSS) 2024 meeting in Orlando with my legs moving like Elvis in concert and my kidneys on overdrive from all the water I drank trying to stay hydrated, I heard the music from the movie Chariots of Fire running through my head.
I looked it up this morning and understood why. “This is the story of two men who run ... not to run ... but to prove something to the world. They will sacrifice anything to achieve their goals.” That pretty much summarizes how I felt after a full day walking the exhibit hall ...
Source: AuntMinnie.com Headlines - March 19, 2024 Category: Radiology Authors: Michael J. Cannavo Tags: Enterprise Imaging Artificial Intelligence Source Type: news
Alcohol-Associated Cirrhosis and Death Are on the Rise: Here's How We Can Help
(MedPage Today) -- Few Americans, including some healthcare professionals, realize that chronic liver disease is now the 9th leading cause of death in the U.S. Even worse, it is the 5th leading cause of death among adults ages 25 to 64 years old... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - March 18, 2024 Category: Psychiatry Source Type: news
‘We actually don’t know much’: the scientists trying to close the knowledge gap in trans healthcare
Researchers are running trials on how hormone therapies affect trans people that will also benefit healthcare for the wider populationWhen Cameron Whitley was diagnosed with kidney failure seven years ago, the news came as a shock. But the situation was about to get worse. His doctor decided the diagnosis meant Whitley ’s hormone therapy had to stop.As a transgender man, now 42, who had taken testosterone for 10 years, the impact was brutal.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 18, 2024 Category: Science Authors: Nicola Davis Science correspondent Tags: Transgender Medical research Health Science Society Source Type: news
GLP-1 RA Reduces Severity of Steatotic Liver Disease in People With HIV
MONDAY, March 18, 2024 -- For people with HIV (PWH) with metabolic-associated steatotic liver disease (MASLD), semaglutide is associated with absolute and relative declines in intrahepatic triglyceride (IHTG) content, according to a study presented... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 18, 2024 Category: Pharmaceuticals Source Type: news
Mirimus' RNAi Technology Helps Advance New Treatment for Liver Tumors and Acute Chronic Liver Diseases
Leveraging Mirimus RNAi technology, a study led by Tuebingen University shows that a new drug has the potential to revolutionize liver surgery and liver transplantation. NEW YORK, March 18, 2024 /PRNewswire-PRWeb/ -- Mirimus, a pioneer in RNAi therapeutic design and CRISPR/Cas9 gene... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - March 18, 2024 Category: Pharmaceuticals Tags: TRI Source Type: news
Chinese Scientists Implant First Pig Liver Into Brain-Dead Human
Who says nothing interesting ever happens in the world anymore? This week, in a "first of its kind" operation, a brain-dead human subject was implanted with the world's first gene-edited pig liver transplant, according to SCMP. In…#scmp (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2024 Category: Consumer Health News Source Type: news
DR ELLIE CANNON: Are statins to blame for my kidney disease?
At a recent check-up I was informed that I had developed chronic kidney disease, a total shock. Could my statin and a blood-pressure pill have caused this problem? (Source: the Mail online | Health)
Source: the Mail online | Health - March 16, 2024 Category: Consumer Health News Source Type: news
She beat a rare liver cancer – and now works with her father to find more cures
Cancer scientist decides to study the tumour that once afflicted his small daughter – and now her work is adding to his project’s successElana Simon was 10 years old when she started to experience severe pains in her abdomen. For two years, puzzled doctors put forward diagnoses including lactose intolerance, Crohn ’s disease and stress. It was not until 2008 that they pinpointed the real cause. Elana was suffering from fibrolamellar carcinoma(FLC), a rare, usually lethal, form of liver cancer.“In a way, it was comforting to have a word for what was wrong with me after so much confusion about my condition,” Elana ...
Source: Guardian Unlimited Science - March 16, 2024 Category: Science Authors: Robin McKie Science Editor Tags: Cancer research Medical research Science UK news Source Type: news
Madrigal wins first U.S. approval for drug to treat liver disease MASH
The Food and Drug Administration on Thursday approved the first medicine developed specifically to treat the serious liver disease known as MASH. The pill, called Rezdiffra, is made by Madrigal Pharmaceuticals. Metabolic…#rezdiffra #metabolic (Source: Reuters: Health)
Source: Reuters: Health - March 16, 2024 Category: Consumer Health News Source Type: news
